Filtros : "SOUZA, ROGÉRIO DE" "Inglaterra" Limpar

Filtros



Refine with date range


  • Source: European respiratory journal. Conference titles: 6th World Symposium on Pulmonary Hypertension. Unidade: FM

    Subjects: HIPERTENSÃO PULMONAR, HEMODINÂMICA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SIMONNEAU, Gerald et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European respiratory journal. Sheffield: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1183/13993003.01913-2018. Acesso em: 10 out. 2024. , 2019
    • APA

      Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., et al. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European respiratory journal. Sheffield: Faculdade de Medicina, Universidade de São Paulo. doi:10.1183/13993003.01913-2018
    • NLM

      Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension [Internet]. European respiratory journal. 2019 ; 53( 1):[citado 2024 out. 10 ] Available from: https://doi.org/10.1183/13993003.01913-2018
    • Vancouver

      Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension [Internet]. European respiratory journal. 2019 ; 53( 1):[citado 2024 out. 10 ] Available from: https://doi.org/10.1183/13993003.01913-2018
  • Source: Therapeutic advances in respiratory disease. Unidade: FM

    Subjects: TROMBOEMBOLISMO, ANTICOAGULANTES, RECIDIVA, HEMORRAGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Caio J et al. Extended anticoagulation after venous thromboembolism: should it be done?. Therapeutic advances in respiratory disease, v. 13, 2019Tradução . . Disponível em: https://doi.org/10.1177/1753466619878556. Acesso em: 10 out. 2024.
    • APA

      Fernandes, C. J., Calderaro, D., Piloto, B., Hoette, S., Jardim, C. V. P., & Souza, R. de. (2019). Extended anticoagulation after venous thromboembolism: should it be done? Therapeutic advances in respiratory disease, 13. doi:10.1177/1753466619878556
    • NLM

      Fernandes CJ, Calderaro D, Piloto B, Hoette S, Jardim CVP, Souza R de. Extended anticoagulation after venous thromboembolism: should it be done? [Internet]. Therapeutic advances in respiratory disease. 2019 ; 13[citado 2024 out. 10 ] Available from: https://doi.org/10.1177/1753466619878556
    • Vancouver

      Fernandes CJ, Calderaro D, Piloto B, Hoette S, Jardim CVP, Souza R de. Extended anticoagulation after venous thromboembolism: should it be done? [Internet]. Therapeutic advances in respiratory disease. 2019 ; 13[citado 2024 out. 10 ] Available from: https://doi.org/10.1177/1753466619878556
  • Source: European respiratory review. Unidade: FM

    Subjects: TROMBOSE, NEOPLASIAS, TROMBOEMBOLISMO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES JR., Caio J et al. Cancer-associated thrombosis: the when, how and why. European respiratory review, v. 28, n. 151, 2019Tradução . . Disponível em: https://doi.org/10.1183/16000617.0119-2018. Acesso em: 10 out. 2024.
    • APA

      Fernandes Jr., C. J., Morinaga, L. T. K., Alves, J. L., Castro, M. A., Calderaro, D., Jardim, C. V. P., & Souza, R. de. (2019). Cancer-associated thrombosis: the when, how and why. European respiratory review, 28( 151). doi:10.1183/16000617.0119-2018
    • NLM

      Fernandes Jr. CJ, Morinaga LTK, Alves JL, Castro MA, Calderaro D, Jardim CVP, Souza R de. Cancer-associated thrombosis: the when, how and why [Internet]. European respiratory review. 2019 ; 28( 151):[citado 2024 out. 10 ] Available from: https://doi.org/10.1183/16000617.0119-2018
    • Vancouver

      Fernandes Jr. CJ, Morinaga LTK, Alves JL, Castro MA, Calderaro D, Jardim CVP, Souza R de. Cancer-associated thrombosis: the when, how and why [Internet]. European respiratory review. 2019 ; 28( 151):[citado 2024 out. 10 ] Available from: https://doi.org/10.1183/16000617.0119-2018
  • Source: Respiratory medicine. Unidade: FM

    Subjects: HIPERTENSÃO PULMONAR (DIAGNÓSTICO;CLASSIFICAÇÃO0, PRESSÃO ARTERIAL, HEMODINÂMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Rogério et al. NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respiratory medicine, v. 101, n. 1, p. 69-75, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.rmed.2006.04.014. Acesso em: 10 out. 2024.
    • APA

      Souza, R., Jardim, C., Fernandes, C. J. C., Lapa, M. S., Rabelo, R., & Humbert, M. (2007). NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respiratory medicine, 101( 1), 69-75. doi:10.1016/j.rmed.2006.04.014
    • NLM

      Souza R, Jardim C, Fernandes CJC, Lapa MS, Rabelo R, Humbert M. NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension [Internet]. Respiratory medicine. 2007 ; 101( 1): 69-75.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.rmed.2006.04.014
    • Vancouver

      Souza R, Jardim C, Fernandes CJC, Lapa MS, Rabelo R, Humbert M. NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension [Internet]. Respiratory medicine. 2007 ; 101( 1): 69-75.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.rmed.2006.04.014
  • Source: Respiratory medicine. Unidade: FM

    Subjects: BRÔNQUIOS (TESTES), LÍQUIDOS E SECREÇÕES (TESTES)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAULIN, E. et al. Functional implications of BAL in the presence of restrictive or obstructive lung disease. Respiratory medicine, v. 101, n. 6, p. 1344-1349, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.rmed.2006.10.003. Acesso em: 10 out. 2024.
    • APA

      Paulin, E., Pedreira Jr., W. L., Souza, R. de, Fiks, I. N., Salge, J. M., & Carvalho, C. R. R. de. (2007). Functional implications of BAL in the presence of restrictive or obstructive lung disease. Respiratory medicine, 101( 6), 1344-1349. doi:10.1016/j.rmed.2006.10.003
    • NLM

      Paulin E, Pedreira Jr. WL, Souza R de, Fiks IN, Salge JM, Carvalho CRR de. Functional implications of BAL in the presence of restrictive or obstructive lung disease [Internet]. Respiratory medicine. 2007 ; 101( 6): 1344-1349.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.rmed.2006.10.003
    • Vancouver

      Paulin E, Pedreira Jr. WL, Souza R de, Fiks IN, Salge JM, Carvalho CRR de. Functional implications of BAL in the presence of restrictive or obstructive lung disease [Internet]. Respiratory medicine. 2007 ; 101( 6): 1344-1349.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.rmed.2006.10.003
  • Source: Journal of Inherited Metabolic Disease. Unidade: FM

    Subjects: HIPERTENSÃO PULMONAR (ESTUDO CLÍNICO), HIPERTENSÃO PULMONAR (ENZIMOLOGIA;FISIOPATOLOGIA), HEMODINÂMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, C. J. C. et al. Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease. Journal of Inherited Metabolic Disease, v. 28, p. 603-605, 2005Tradução . . Disponível em: https://doi.org/10.1007/s10545-005-0603-y. Acesso em: 10 out. 2024.
    • APA

      Fernandes, C. J. C., Jardim, C., Carvalho, L. A. S., Farias, A. Q., Terra Filho, M., & Souza, R. (2005). Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease. Journal of Inherited Metabolic Disease, 28, 603-605. doi:10.1007/s10545-005-0603-y
    • NLM

      Fernandes CJC, Jardim C, Carvalho LAS, Farias AQ, Terra Filho M, Souza R. Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease [Internet]. Journal of Inherited Metabolic Disease. 2005 ; 28 603-605.[citado 2024 out. 10 ] Available from: https://doi.org/10.1007/s10545-005-0603-y
    • Vancouver

      Fernandes CJC, Jardim C, Carvalho LAS, Farias AQ, Terra Filho M, Souza R. Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease [Internet]. Journal of Inherited Metabolic Disease. 2005 ; 28 603-605.[citado 2024 out. 10 ] Available from: https://doi.org/10.1007/s10545-005-0603-y
  • Source: Current Medical Research and Opinions. Unidade: FM

    Subjects: HIPERTENSÃO PULMONAR (TERAPIA), HIPERTENSÃO PULMONAR (EFEITOS DE DROGAS)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Rogerio de et al. Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension. Current Medical Research and Opinions, v. 21, n. 6, p. 907-911, 2005Tradução . . Disponível em: https://doi.org/10.1185/030079905x46232. Acesso em: 10 out. 2024.
    • APA

      Souza, R. de, Jardim, C., Martins, B., Cortopassi, F., Yaksic, M., Rabelo, R., & Bogossian, H. (2005). Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension. Current Medical Research and Opinions, 21( 6), 907-911. doi:10.1185/030079905x46232
    • NLM

      Souza R de, Jardim C, Martins B, Cortopassi F, Yaksic M, Rabelo R, Bogossian H. Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension [Internet]. Current Medical Research and Opinions. 2005 ; 21( 6): 907-911.[citado 2024 out. 10 ] Available from: https://doi.org/10.1185/030079905x46232
    • Vancouver

      Souza R de, Jardim C, Martins B, Cortopassi F, Yaksic M, Rabelo R, Bogossian H. Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension [Internet]. Current Medical Research and Opinions. 2005 ; 21( 6): 907-911.[citado 2024 out. 10 ] Available from: https://doi.org/10.1185/030079905x46232

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024